New developments in the diagnosis and treatment of thyroid cancer
- PMID: 23797834
- PMCID: PMC3800231
- DOI: 10.3322/caac.21195
New developments in the diagnosis and treatment of thyroid cancer
Abstract
Thyroid cancer exists in several forms. Differentiated thyroid cancers include those with papillary and follicular histologies. These tumors exist along a spectrum of differentiation, and their incidence continues to climb. A number of advances in the diagnosis and treatment of differentiated thyroid cancers now exist. These include molecular diagnostics and more advanced strategies for risk stratification. Medullary cancer arises from the parafollicular cells and not the follicular cells. Therefore, diagnosis and treatment differs from those of differentiated thyroid tumors. Genetic testing and newer adjuvant therapies have changed the diagnosis and treatment of medullary thyroid cancer. This review will focus on the epidemiology, diagnosis, workup, and treatment of both differentiated and medullary thyroid cancers, focusing specifically on newer developments in the field.
Keywords: diagnosis; epidemiology; follicular thyroid cancer; medullary thyroid cancer; papillary thyroid cancer; thyroid cancer; treatment.
© 2013 American Cancer Society, Inc.
Figures
Similar articles
-
Thyroid cancer: a lethal endocrine neoplasm.Ann Intern Med. 1991 Jul 15;115(2):133-47. doi: 10.7326/0003-4819-115-2-133. Ann Intern Med. 1991. PMID: 2058861 Review.
-
[PREOPERATIVE DIAGNOSTICS OF THYROID MEDULLARY CARCINOMA WITH EMPHASIS ON CYTOMORPHOLOGICAL FEATURES AND DIFFERENTIAL DIAGNOSIS OF PRIMARY AND SECONDARY THYROID TUMORS].Acta Med Croatica. 2014 Dec;68(4-5):383-8. Acta Med Croatica. 2014. PMID: 26285471 Croatian.
-
Genetic mutations in thyroid carcinoma.Minerva Endocrinol. 2009 Mar;34(1):11-28. Minerva Endocrinol. 2009. PMID: 19209125 Review.
-
Diagnosis and Management of Hereditary Thyroid Cancer.Recent Results Cancer Res. 2016;205:29-44. doi: 10.1007/978-3-319-29998-3_3. Recent Results Cancer Res. 2016. PMID: 27075347
-
Diagnostic and therapeutic aspects in medullary thyroid carcinoma.Chirurgia (Bucur). 2006 Mar-Apr;101(2):121-6. Chirurgia (Bucur). 2006. PMID: 16752676 Review.
Cited by
-
A panel of four genes accurately differentiates benign from malignant thyroid nodules.J Exp Clin Cancer Res. 2016 Oct 28;35(1):169. doi: 10.1186/s13046-016-0447-3. J Exp Clin Cancer Res. 2016. PMID: 27793213 Free PMC article.
-
Plasma ω-3 and ω-6 fatty acids in thyroid diseases.Oncol Lett. 2018 Oct;16(4):5433-5440. doi: 10.3892/ol.2018.9288. Epub 2018 Aug 9. Oncol Lett. 2018. PMID: 30250615 Free PMC article.
-
F12 as a reliable diagnostic and prognostic biomarker associated with immune infiltration in papillary thyroid cancer.Aging (Albany NY). 2022 Apr 28;14(8):3687-3704. doi: 10.18632/aging.204037. Epub 2022 Apr 28. Aging (Albany NY). 2022. PMID: 35483340 Free PMC article.
-
lncRNA CDKN2B-AS1 Could Be an Indicator to Identify Prognosis and Status of Immune Microenvironment in Thyroid Cancer.Dis Markers. 2022 Apr 8;2022:4317480. doi: 10.1155/2022/4317480. eCollection 2022. Dis Markers. 2022. PMID: 35432631 Free PMC article.
-
Nuclear interaction of Arp2/3 complex and BRAFV600E promotes aggressive behavior and vemurafenib resistance of thyroid cancer.Am J Cancer Res. 2022 Jul 15;12(7):3014-3033. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968344 Free PMC article.
References
-
- Clark OH. Thyroid cancer and lymph node metastases. J Surg Oncol. 2011;103:615–8. - PubMed
-
- Sippel RS, Chen H. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid. 2009;19(12):1373–80. - PubMed
-
- Patel KN, Shaha AR. Poorly differentiated and anaplastic thyroid cancer. Cancer Control. 2006;13:119–28. - PubMed
-
- Udelsman R, Chen H. The current management of thyroid cancer. Adv Surg. 1999;33:1–27. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical